SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/7B6F4C786959F5EFACBDDC7ADD0C3EABA770DD6DD802C98ECE4B7C308CBB06FC3479C8D856DB0B44DDF0F4A17F05A8B1>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/7B6F4C786959F5EFACBDDC7ADD0C3EABA770DD6DD802C98ECE4B7C308CBB06FC3479C8D856DB0B44DDF0F4A17F05A8B1
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/7B6F4C786959F5EFACBDDC7ADD0C3EABA770DD6DD802C98ECE4B7C308CBB06FC3479C8D856DB0B44DDF0F4A17F05A8B1
http://www.w3.org/2000/01/rdf-schema#comment
"When intensive chemotherapy was used the TCF3-PBX1 was associated with a favorable outcome in childhood pre-B ALL."
xsd:string
http://purl.uniprot.org/uniprot/#_83AED1EC7796510A61CB8D4ACE1826E57FE99A3A185226E5F0D7C01E21E3D994B0E1FDE23EDC086E18D005BAE3C462CE
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/7B6F4C786959F5EFACBDDC7ADD0C3EABA770DD6DD802C98ECE4B7C308CBB06FC3479C8D856DB0B44DDF0F4A17F05A8B1
http://purl.uniprot.org/uniprot/A8K5V0
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/7B6F4C786959F5EFACBDDC7ADD0C3EABA770DD6DD802C98ECE4B7C308CBB06FC3479C8D856DB0B44DDF0F4A17F05A8B1
http://purl.uniprot.org/uniprot/#_A8K5V0-mappedCitation-25551271
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/7B6F4C786959F5EFACBDDC7ADD0C3EABA770DD6DD802C98ECE4B7C308CBB06FC3479C8D856DB0B44DDF0F4A17F05A8B1